1,661
Views
15
CrossRef citations to date
0
Altmetric
Articles

Cannabis, alcohol and cigarette use during the acute post-concussion period

, , , , , & ORCID Icon show all
Pages 42-51 | Received 07 Apr 2019, Accepted 09 Oct 2019, Published online: 17 Oct 2019

References

  • McCrory P, Meeuwisse W, Dvorak J, Aubry M, Bailes J, Broglio S, Cantu RC, Cassidy D, Echemendia RJ, Castellani RJ, et al. Consensus statement on concussion in sport-the 5th international conference on concussion in sport held in Berlin, October 2016. Br J Sports Med. 2017;51:838–47.
  • Thomas DG, Apps JN, Hoffmann RG, McCrea M, Hammeke T. Benefits of strict rest after acute concussion: a randomized controlled trial. Pediatrics. 2015;135:213–23.doi:10.1542/peds.2014-0966.
  • Brown NJ, Mannix RC, O’Brien MJ, Gostine D, Collins MW, Meehan WP 3rd. Effect of cognitive activity level on duration of post-concussion symptoms. Pediatrics. 2014;133:e299–304.doi:10.1542/peds.2013-2125.
  • Lawrence DW, Richards D, Comper P, Hutchison MG. Earlier time to aerobic exercise is associated with faster recovery following acute sport concussion. PLoS One. 2018;13:e0196062.doi:10.1371/journal.pone.0196062.
  • Grool AM, Aglipay M, Momoli F, Meehan WP 3rd, Freedman SB, Yeates KO, Gravel J, Gagnon I, Boutis K, Meeuwisse W, et al. Association between early participation in physical activity following acute concussion and persistent postconcussive symptoms in children and adolescents. JAMA. 2016;316:2504–14.
  • Lal A, Kolakowsky-Hayner SA, Ghajar J, Balamane M. The effect of physical exercise after a concussion: a systematic review and meta-analysis. Am J Sports Med. 2017;46:743-52.363546517706137.
  • Schneider KJ, Leddy JJ, Guskiewicz KM, Seifert T, McCrea M, Silverberg ND, Feddermann-Demont N, Iverson GL, Hayden A, Makdissi M. Rest and treatment/rehabilitation following sport-related concussion: a systematic review. Br J Sports Med. 2017;51:930–34.doi:10.1136/bjsports-2016-097475.
  • Hingley S, Ross J. Guidelines for diagnosing and managing paediatric concussion: Ontario neurotrauma foundation guideline. Arch Dis Child Educ Pract Ed. 2016;101:58–60.doi:10.1136/archdischild-2014-307252.
  • Peretti-Watel P, Guagliardo V, Verger P, Pruvost J, Mignon P, Obadia Y. Sporting activity and drug use: alcohol, cigarette and cannabis use among elite student athletes. Addiction. 2003;98:1249–56.doi:10.1046/j.1360-0443.2003.00490.x.
  • (CCDUS) CCoSAaA. Canadian drug summary: cannabis; 2018 [accessed 2019 March 6]. http://www.ccsa.ca/Resource Library/CCSA-Canadian-Drug-Summary-Cannabis-2018-en.pdf.
  • Canada S Canadian tobacco, alcohol and drugs survey, 2017; 2018 [accessed 2019 March 6]. https://www150.statcan.gc.ca/n1/en/daily-quotidien/181030/dq181030b-eng.pdf?st=u9941PWA.
  • Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature. 2001;413:527–31.doi:10.1038/35097089.
  • van der Naalt J, Timmerman ME, de Koning ME, van der Horn HJ, Scheenen ME, Jacobs B, Hageman G, Yilmaz T, Roks G, Spikman JM. Early predictors of outcome after mild traumatic brain injury (UPFRONT): an observational cohort study. Lancet Neurol. 2017;16:532–40.doi:10.1016/S1474-4422(17)30117-5.
  • Brody AL, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, London ED, Nurmi EL, Seaman LC, Mandelkern MA. Effect of cigarette smoking on a marker for neuroinflammation: a [(11)C]DAA1106 positron emission tomography study. Neuropsychopharmacology. 2018;43:925.doi:10.1038/npp.2017.261.
  • Khanna A, Guo M, Mehra M, Royal W 3rd. Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains. J Neuroimmunol. 2013;254:69–75.doi:10.1016/j.jneuroim.2012.09.006.
  • Durazzo TC, Abadjian L, Kincaid A, Bilovsky-Muniz T, Boreta L, Gauger GE. The influence of chronic cigarette smoking on neurocognitive recovery after mild traumatic brain injury. J Neurotrauma. 2013;30:1013–22.doi:10.1089/neu.2012.2676.
  • Albrecht JS, Afshar M, Stein DM, Smith GS. Association of alcohol with mortality after traumatic brain injury. Am J Epidemiol. 2018;187:233–41.doi:10.1093/aje/kwx254.
  • Tien HC, Tremblay LN, Rizoli SB, Gelberg J, Chughtai T, Tikuisis P, Shek P, Brenneman FD. Association between alcohol and mortality in patients with severe traumatic head injury. Arch Surg. 2006;141:1185–91.doi:10.1001/archsurg.141.12.1185.
  • O’Phelan K, McArthur DL, Chang CW, Green D, Hovda DA. The impact of substance abuse on mortality in patients with severe traumatic brain injury. J Trauma. 2008;65:674–77.doi:10.1097/TA.0b013e31817db0a5.
  • Berry C, Ley EJ, Margulies DR, Mirocha J, Bukur M, Malinoski D, Salim A. Correlating the blood alcohol concentration with outcome after traumatic brain injury: too much is not a bad thing. Am Surg. 2011;77:1416–19.
  • Berry C, Salim A, Alban R, Mirocha J, Margulies DR, Ley EJ. Serum ethanol levels in patients with moderate to severe traumatic brain injury influence outcomes: a surprising finding. Am Surg. 2010;76:1067–70.
  • Jacobs B, Beems T, Stulemeijer M, van Vugt AB, van der Vliet TM, Borm GF, Vos PE. Outcome prediction in mild traumatic brain injury: age and clinical variables are stronger predictors than CT abnormalities. J Neurotrauma. 2010;27:655–68.doi:10.1089/neu.2009.1059.
  • Scheenen ME, de Koning ME, van der Horn HJ, Roks G, Yilmaz T, van der Naalt J, Spikman JM. Acute alcohol intoxication in patients with mild traumatic brain injury: characteristics, recovery, and outcome. J Neurotrauma. 2016;33:339–45.doi:10.1089/neu.2015.3926.
  • Opreanu RC, Kuhn D, Basson MD. Influence of alcohol on mortality in traumatic brain injury. J Am Coll Surg. 2010;210:997–1007.doi:10.1016/j.jamcollsurg.2010.01.036.
  • Aizpurua-Olaizola O, Soydaner U, Ozturk E, Schibano D, Simsir Y, Navarro P, Etxebarria N, Usobiaga A. Evolution of the cannabinoid and terpene content during the growth of cannabis sativa plants from different chemotypes. J Nat Prod. 2016;79:324–31.doi:10.1021/acs.jnatprod.5b00949.
  • Schurman LD, Lichtman AH. Endocannabinoids: a promising impact for traumatic brain injury. Front Pharmacol. 2017;8:69.doi:10.3389/fphar.2017.00069.
  • Nguyen BM, Kim D, Bricker S, Bongard F, Neville A, Putnam B, Smith J, Plurad D. Effect of marijuana use on outcomes in traumatic brain injury. Am Surg. 2014;80:979–83.
  • Knoller N, Levi L, Shoshan I, Reichenthal E, Razon N, Rappaport ZH, Biegon A. Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial. Crit Care Med. 2002;30:548–54.doi:10.1097/00003246-200203000-00009.
  • Maas AI, Murray G, Henney H 3rd, Kassem N, Legrand V, Mangelus M, Muizelaar JP, Stocchetti N, Knoller N, Pharmos T. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol. 2006;5:38–45.doi:10.1016/S1474-4422(05)70253-2.
  • Canada G The chief public health officer’s report on the state of public health in Canada 2015: alcohol consumption in Canada; 2016 [accessed 2019 March 6]. http://healthycanadians.gc.ca/publications/department-ministere/state-public-health-alcohol-2015-etat-sante-publique-alcool/alt/state-phac-alcohol-2015-etat-aspc-alcool-eng.pdf.
  • Piper BJ, DeKeuster RM, Beals ML, Cobb CM, Burchman CA, Perkinson L, Lynn ST, Nichols SD, Abess AT. Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. J Psychopharmacol. 2017;31:569–75.doi:10.1177/0269881117699616.
  • Bachhuber M, Arnsten JH, Wurm G. Use of cannabis to relieve pain and promote sleep by customers at an adult use dispensary. J Psychoactive Drugs. 2019. Epub ahead of print. doi:10.1080/02791072.02792019.01626953.
  • Seifert T. The relationship of migraine and other headache disorders to concussion. Handb Clin Neurol. 2018;158:119–26.doi:10.1016/B978-0-444-63954-7.00012-4.
  • Stockings E, Campbell G, Hall WD, Nielsen S, Zagic D, Rahman R, Murnion B, Farrell M, Weier M, Degenhardt L. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain. 2018;159:1932–54.doi:10.1097/j.pain.0000000000001293.
  • Crowe MS, Nass SR, Gabella KM, Kinsey SG. The endocannabinoid system modulates stress, emotionality, and inflammation. Brain Behav Immun. 2014;42:1–5.doi:10.1016/j.bbi.2014.06.007.
  • Babson KA, Sottile J, Morabito D. Cannabis, cannabinoids, and sleep: a review of the literature. Curr Psychiatry Rep. 2017;19:23.doi:10.1007/s11920-017-0775-9.
  • Zale E, Maisto SA, Ditre JW. Interrelations between pain and alcohol: an integrative review. Clinical Psychology Review. 2015;37:57–71.doi:10.1016/j.cpr.2015.02.005.
  • Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, Greenwood SM, Roberts C, Checketts D, VanLandingham KE, et al. Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome. N Engl J Med. 2018;378:1888–97.
  • Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA, Wright S. Cannabidiol in dravet syndrome study G. trial of cannabidiol for drug-resistant seizures in the dravet syndrome. N Engl J Med. 2017;376:2011–20.doi:10.1056/NEJMoa1611618.
  • Devinsky O, Marsh E, Friedman D, Thiele E, Laux L, Sullivan J, Miller I, Flamini R, Wilfong A, Filloux F, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016;15:270–78.
  • Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011;72:735–44.doi:10.1111/j.1365-2125.2011.03970.x.
  • Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H. Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain. 2013;14:136–48.doi:10.1016/j.jpain.2012.10.009.
  • Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313:2456–73.
  • Yanes JA, McKinnell ZE, Reid MA, Busler JN, Michel JS, Pangelinan MM, Sutherland MT, Younger JW, Gonzalez R, Robinson JL. Effects of cannabinoid administration for pain: A meta-analysis and meta-regression. Exp Clin Psychopharmacol. 2019;27:370–82.doi:10.1037/pha0000281.
  • Campbell VA, Gowran A. Alzheimer’s disease; taking the edge off with cannabinoids? Br J Pharmacol. 2007;152:655–62.doi:10.1038/sj.bjp.0707446.
  • Sagredo O, Ramos JA, Decio A, Mechoulam R, Fernandez-Ruiz J. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors. Eur J Neurosci. 2007;26:843–51.doi:10.1111/j.1460-9568.2007.05717.x.
  • Sagredo O, Pazos MR, Valdeolivas S, Fernandez-Ruiz J. Cannabinoids: novel medicines for the treatment of Huntington’s disease. Recent Pat CNS Drug Discov. 2012;7:41–48.
  • Sagredo O, Pazos MR, Satta V, Ramos JA, Pertwee RG, Fernandez-Ruiz J. Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease. J Neurosci Res. 2011;89:1509–18.doi:10.1002/jnr.22682.
  • Sagredo O, Garcia-Arencibia M, de Lago E, Finetti S, Decio A, Fernandez-Ruiz J. Cannabinoids and neuroprotection in basal ganglia disorders. Mol Neurobiol. 2007;36:82–91.doi:10.1007/s12035-007-0004-3.
  • Vaney C, Heinzel-Gutenbrunner M, Jobin P, Tschopp F, Gattlen B, Hagen U, Schnelle M, Reif M. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study. Mult Scler. 2004;10:417–24.doi:10.1191/1352458504ms1048oa.
  • Baron EP. Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip it’s been. Headache. 2015;55:885–916.doi:10.1111/head.12570.
  • Hayatbakhsh MR, Najman JM, Jamrozik K, Mamun AA, Alati R, Bor W. Cannabis and anxiety and depression in young adults: a large prospective study. J Am Acad Child Adolesc Psychiatry. 2007;46:408–17.doi:10.1097/chi.0b013e31802dc54d.
  • Rumalla K, Reddy AY, Mittal MK. Recreational marijuana use and acute ischemic stroke: A population-based analysis of hospitalized patients in the United States. J Neurol Sci. 2016;364:191–96.doi:10.1016/j.jns.2016.01.066.
  • Nguyen BM, Kim D, Bricker S, Bongard F, Neville A, Putnam A, SMith J, Plurad D. Effect of marijuana use on outcomes in traumatic brain injury. The American Surgeon. 2014;10:979–83.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.